Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ebru Ortac Ersoy"'
Autor:
Mehmet Yildirim, Burcin Halacli, Mehmet Yasir Pektezel, Berrin Er, Ismail Tuna Geldigitti, Gulay Tok, Ebru Ortac Ersoy, Arzu Topeli
Publikováno v:
Acute and Critical Care, Vol 37, Iss 2, Pp 168-176 (2022)
Background Coronavirus disease 2019 (COVID-19) is one of the biggest pandemic causing acute respiratory failure (ARF) in the last century. Seasonal influenza carries high mortality, as well. The aim of this study was to compare features and outcomes
Externí odkaz:
https://doaj.org/article/2dfe9d229505486198088d82075a32ec
Publikováno v:
Respiratory Medicine Case Reports, Vol 15, Iss C, Pp 92-94 (2015)
Glutaric aciduria (GTA) type II can be seen as late onset form with myopathic phenotype. We present a case of a 19-year old female with progressive muscle weakness was admitted in intensive care unit (ICU) with respiratory failure and acute renal fai
Externí odkaz:
https://doaj.org/article/bc7e929a10ad456cb95f0fdc0b2a2bc9
Publikováno v:
Journal of Intensive Care Medicine. 38:70-77
Purpose We aimed to evaluate the relation between admission COVID-19 associated hyperinflammatory syndrome (cHIS) score and intensive care unit (ICU) outcomes. Materials and Methods Patients with laboratory confirmed COVID-19 admitted to our ICU betw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3e66e54b7244e7ef9e6696fbe007113
https://doi.org/10.1177/08850666221131265
https://doi.org/10.1177/08850666221131265
Autor:
Burcin Halacli, Gulay Tok, Mehmet Yildirim, Ismail Tuna Geldigitti, Ebru Ortac Ersoy, Arzu Topeli
Publikováno v:
Mediterranean Journal of Infection Microbes and Antimicrobials.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0aa4fa6004a0f84cf3e721f16aed633b
https://doi.org/10.4274/mjima.galenos.2023.2022.1
https://doi.org/10.4274/mjima.galenos.2023.2022.1
Autor:
Burcin Halacli, Mehmet Yildirim, Esat Kivanc Kaya, Ege Ulusoydan, Ebru Ortac Ersoy, Arzu Topeli
Publikováno v:
Chronic Illness. :174239532311613
Objectives To evaluate the presence of chronic critical illness (CCI) in COVID-19 patients and compare clinical characteristics and prognosis of patients with and without CCI admitted to intensive care unit (ICU). Methods It was a retrospective, obse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2d30ea16788e91e5abc1e7365717ec4
https://doi.org/10.1177/17423953231161333
https://doi.org/10.1177/17423953231161333
Autor:
Ebru Ortac Ersoy
Publikováno v:
Teaching Pearls in Noninvasive Mechanical Ventilation ISBN: 9783030712976
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::497ae89757fe444e037cd0fe67b575c7
https://doi.org/10.1007/978-3-030-71298-3_21
https://doi.org/10.1007/978-3-030-71298-3_21
Autor:
Ebru Ortac Ersoy
Publikováno v:
Journal of Critical and Intensive Care.
The 2019 coronavirus disease (COVID-19) epidemic is currently spreading worldwide; in particular, Turkey has been facing the outbreak since March 11st. Hospital and Intensive Care Unit (ICU) admissions are dependent on the severity of illness and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b62d50fb021211e380df2d7b8af7aab
https://doi.org/10.37678/dcybd.2020.2376
https://doi.org/10.37678/dcybd.2020.2376
Autor:
Fatma Yildirim, Serpil Ocal, Ebru Ortac Ersoy, Kazim Rollas, Burcu Basarik Aydogan, Turkish Respiratory Society Intensive Care Working Group
Publikováno v:
Eurasian Journal of Pulmonology, Vol 19, Iss 2, Pp 54-64 (2017)
High-flow nasal oxygen (HFNO) therapy has several physiological advantages over traditional oxygen therapy devices, including decreased nasopharyngeal resistance, washing out of the nasopharyngeal dead space, generation of positive pressure in the ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6138aead03f9cb7dd35279e70402cf8
https://doi.org/10.5152/ejp.2017.38258
https://doi.org/10.5152/ejp.2017.38258
Publikováno v:
The clinical respiratory journal. 11(6)
Chronic obstructive pulmonary disease (COPD) remains a globally significant cause of mortality, although COPD mortality varies from country to country, and across different regions within each country. The primary objective of this study was to deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::be791bcf5384b57cdffb391dc8d5c2d5
https://pubmed.ncbi.nlm.nih.gov/27117626
https://pubmed.ncbi.nlm.nih.gov/27117626
Autor:
Burçin HALAÇLI, Gülay TÖK, Mehmet YILDIRIM, İsmail Tuna GELDİGİTTİ, Ebru ORTAÇ ERSOY, Arzu TOPELİ
Publikováno v:
Mediterranean Journal of Infection, Microbes and Antimicrobials, Vol 12, Iss 1 (2023)
Introduction: Dexamethasone is the first medication that improved survival in patients with Coronavirus disease-2019 (COVID-19); however, the effects of corticosteroids with different cumulative doses on disease outcome must be elucidated. Our study
Externí odkaz:
https://doaj.org/article/a8f11a7bcb324c488e8079eb9c8651c6